A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer
-
Tan, E. H. (National Cancer Centre (Singapur). Department of Medical Oncology)
;
Ramlau, Rodryg (Regional Lung Disease Centre (Poznan). Department of Oncology) ;
Pluzanska, A. (Regional Oncology Centre (Lodz, Polònia). Oncological Chemotherapy Clinic) ;
Kuo, H. -P. (Chang Gung Memorial Hospital (Linkou, Taiwan). Department of Thoracic Medicine) ;
Reck, Martin (Hospital Grosshansdorf (Grosshansdorf, Alemanya). Department of Thoracic Oncology) ;
Milanowski, J. (Akademia Medyczna w Lublinie (Lublin, Polònia). Department of Pneumology, Oncology and Allergology) ;
Au, J. S. -K. (Queen Elizabeth Hospital (Hong Kong). Department of Clinical Oncology) ;
Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ;
Yang, P. -C. (National Taiwan University Hospital (Taipei, Taiwan)) ;
Damyanov, D. (Specialized Hospital for Active Treatment in Oncology (Sofia, Bulgaria)) ;
Orlov, S. (Pavlov State Medical University. Research Institute of Pulmonology (Sant Petersburg, Rússia)) ;
Akimov, Mikhail (Hoffmann-La Roche (Basel, Suïssa)) ;
Delmar, P. (Hoffmann-La Roche (Basel, Suïssa)) ;
Essioux, L. (Hoffmann-La Roche (Basel, Suïssa)) ;
Hillenbach, C. (Hoffmann-La Roche (Basel, Suïssa)) ;
Klughammer, B. (Hoffmann-La Roche (Basel, Suïssa)) ;
McLoughlin, P. (Hoffmann-La Roche (Basel, Suïssa)) ;
Baselga Torres, Josep, 1959-2021, (Hospital Universitari Vall d'Hebron)